Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults

Previous studies have consistently suggested that the varepsilon4 allele of apolipoprotein E (APOE) gene is a major risk factor for Alzheimer's disease (AD). However, whether the varepsilon2 allele, a possible protective factor for AD, will express its protective effect in terms of cortical thickness in healthy elderly carriers is unclear. The goal of this study is to clarify the effects of APOE genotypes on cortical thickness in nondemented elderly subjects. We used 164 healthy, cognitively normal, elderly subjects, who were grouped into varepsilon2 carriers, varepsilon3 homozygotes, and varepsilon4 carriers respectively. The APOE varepsilon2 carriers had a significant thicker (corrected p<0.05) cortical thickness in the superior temporal cortex compared with the varepsilon3 homozygotes. In addition to this area, the APOE varepsilon2 carriers had a significantly thicker region in the dorsolateral prefrontal cortex (corrected p<0.05) than did the varepsilon4 carriers. These findings suggest that the different alleles of the APOE gene have distinct neuroanatomic effects in elderly healthy subjects and may play specific roles in the development of AD.

[1]  L. Thal,et al.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease , 2004, Neurology.

[2]  J. Trojanowski,et al.  Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics , 2007, Nature Reviews Drug Discovery.

[3]  Amy J. Jak,et al.  Differential Cross-Sectional and Longitudinal Impact of APOE Genotype on Hippocampal Volumes in Nondemented Older Adults , 2007, Dementia and Geriatric Cognitive Disorders.

[4]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[5]  Moo K. Chung,et al.  Cortical thickness analysis in autism with heat kernel smoothing , 2005, NeuroImage.

[6]  Alan C. Evans,et al.  A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  John J Sidtis,et al.  Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.

[8]  H. Soininen,et al.  CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease , 1998, Neurology.

[9]  W. M. van der Flier,et al.  CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age. , 2009, Journal of Alzheimer's disease : JAD.

[10]  C. Duyckaerts,et al.  Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer’s disease , 1998, Acta Neuropathologica.

[11]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[12]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[13]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Scott,et al.  Identification of a pathway for intelligible speech in the left temporal lobe. , 2000, Brain : a journal of neurology.

[15]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[16]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[17]  A. Dale,et al.  High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.

[18]  Anders M. Fjell,et al.  Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4 , 2008, Neurobiology of Aging.

[19]  C. Jack,et al.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.

[20]  L M Bouter,et al.  Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly , 2001, Neurology.

[21]  Kamil Ugurbil,et al.  A functional magnetic resonance imaging study of the role of left posterior superior temporal gyrus in speech production: implications for the explanation of conduction aphasia , 2000, Neuroscience Letters.

[22]  David A. Bennett,et al.  The apolipoprotein E ε2 allele and decline in episodic memory , 2002 .

[23]  Paul M. Thompson,et al.  Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers , 2008, NeuroImage.

[24]  Frank Em.  Effect of Alzheimer's disease on communication function. , 1994 .

[25]  G A Johnson,et al.  In vitro MR microscopy of the hippocampus in Alzheimer's disease , 1993, Neurology.

[26]  Hans Förstl,et al.  Clinical features of Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[27]  Ge Li,et al.  Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. , 2006, Archives of neurology.

[28]  C. Ranganath,et al.  Dorsolateral Prefrontal Cortex Promotes Long-Term Memory Formation through Its Role in Working Memory Organization , 2006, The Journal of Neuroscience.

[29]  K. Blennow,et al.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease , 2009, Neurobiology of Aging.

[30]  Anders M. Dale,et al.  Selective increase of cortical thickness in high-performing elderly—structural indices of optimal cognitive aging , 2006, NeuroImage.

[31]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[32]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[33]  J. Cohen,et al.  Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. , 2000, Science.

[34]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[35]  R A Crowther,et al.  Tau Proteins and Neurofibrillary Degeneration , 1991, Brain pathology.

[36]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[37]  C. Duyckaerts,et al.  Modeling the Relation Between Neurofibrillary Tangles and Intellectual Status , 1997, Neurobiology of Aging.

[38]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Hilkka Soininen,et al.  Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer’s disease , 2000, Neurobiology of Aging.